WilmsTumor
1 clinical trials · Condition
| Record | Firm | Date |
|---|---|---|
| A Phase I Study of Vorinostat and Bortezomib in Children With Refractory of Recurrent Solid Tumors, Including CNS Tumors and Lymphomas (NCT01132911) | National Cancer Institute (NCI) | 2010-05-10 |
Track WilmsTumor automatically
Every clearance here is in the API, with alerts when new ones post.